Credits

Website created by Cabengo LLC with Studio Mobile

Maintained by The Department of Art as Applied to Medicine, Johns Hopkins University School of Medicine

Testimonial

NTAP is a terrific new funding opportunity congregating scientists and clinicians interested in NF1. NTAP will change the NF1 research landscape by promoting and supporting out-of-the-box thinking, hopefully leading to new discoveries with the potential of revolutionizing clinical management of NF1 tumors.-- Marco Giovannini, M.D., Ph.D.

Professor-in-Residence, Director, UCLA Head and Neck Surgery

I liked how NTAP was more focused on the outcome and the potential for direct clinical translation, as opposed to more traditional funding mechanisms that can place a greater emphasis on the methodology rather than the clinical significance.-- Kakajan Komurov, Ph.D.

Assistant Professor, UC Department of Pediatrics, Cincinnati Children's Hospital

The NTAP model provides a nimble and innovative way to overcome bottlenecks in research on plexiform neurofibromas that would be impossible for funding agencies such as NIH or DOD to match. It has already made a difference in stimulating in vitro models for drug screening and in preclinical testing. The program is limited only by the imagination of the scientific community and has demonstrated an ability to quickly rise to meet both research needs and opportunities.-- Bruce Korf, M.D., Ph.D.

Professor, Department of Genetics, The University of Alabama at Birmingham